Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-07-16

Clinical Trial Update: Bioequivalence of Losartan and Hydrochlorothiazide (HCTZ) Combination Tablet and Coadministration of Its Components (0954A-306) [Phase 1]

View source ↗

Summary

A Phase 1 trial assessed the bioequivalence of a losartan-HCTZ combination tablet versus coadministration of its components for hypertension; results completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROCHLOROTHIAZIDE (hydrochlorothiazide)
  • Losartan (losartan)
  • losartan-HCTZ combination tablet (losartan and hydrochlorothiazide combination)

Snippet

Sponsor: Organon and Co | Conditions: Hypertension | Phase 1 | Status: COMPLETED | Results posted: 2010-07-16